Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 146

1.

Pathogen-boosted adoptive cell transfer therapy induces endogenous antitumor immunity through antigen spreading.

Xin G, Khatun A, Topchyan P, Zander R, Volberding PJ, Chen Y, Shen J, Fu C, Jiang A, See WA, Cui W.

Cancer Immunol Res. 2019 Nov 12. pii: canimm.0251.2019. doi: 10.1158/2326-6066.CIR-19-0251. [Epub ahead of print]

PMID:
31719059
2.

Enzalutamide Induced Feed-Forward Signaling Loop Promotes Therapy-Resistant Prostate Cancer Growth Providing an Exploitable Molecular Target for Jak2 Inhibitors.

Udhane V, Maranto C, Hoang DT, Gu L, Erickson A, Devi S, Talati PG, Banerjee A, Iczkowski KA, Jacobsohn K, See WA, Mirtti T, Kilari D, Nevalainen MT.

Mol Cancer Ther. 2019 Sep 23. pii: molcanther.0508.2019. doi: 10.1158/1535-7163.MCT-19-0508. [Epub ahead of print]

PMID:
31548294
3.

Digital Rectal Examination Remains a Key Prognostic Tool for Prostate Cancer: A National Cancer Database Review.

Borkenhagen JF, Eastwood D, Kilari D, See WA, Van Wickle JD, Lawton CA, Hall WA.

J Natl Compr Canc Netw. 2019 Jul 1;17(7):829-837. doi: 10.6004/jnccn.2018.7278.

PMID:
31319388
4.

Positive STAT5 Protein and Locus Amplification Status Predicts Recurrence after Radical Prostatectomy to Assist Clinical Precision Management of Prostate Cancer.

Haddad BR, Erickson A, Udhane V, LaViolette PS, Rone JD, Kallajoki MA, See WA, Rannikko A, Mirtti T, Nevalainen MT.

Cancer Epidemiol Biomarkers Prev. 2019 Oct;28(10):1642-1651. doi: 10.1158/1055-9965.EPI-18-1358. Epub 2019 Jul 10.

PMID:
31292140
5.

Gleason Probability Maps: A Radiomics Tool for Mapping Prostate Cancer Likelihood in MRI Space.

McGarry SD, Bukowy JD, Iczkowski KA, Unteriner JG, Duvnjak P, Lowman AK, Jacobsohn K, Hohenwalter M, Griffin MO, Barrington AW, Foss HE, Keuter T, Hurrell SL, See WA, Nevalainen MT, Banerjee A, LaViolette PS.

Tomography. 2019 Mar;5(1):127-134. doi: 10.18383/j.tom.2018.00033.

6.

The implications of fellowship expansion on future pediatric urologist surgical volumes.

Groth TW, See WA, Ramsay S, Cooper CS, Kryger JV.

J Pediatr Urol. 2018 Jun;14(3):246-250. doi: 10.1016/j.jpurol.2017.10.013. Epub 2017 Nov 27.

PMID:
29958643
7.

Radio-pathomic Maps of Epithelium and Lumen Density Predict the Location of High-Grade Prostate Cancer.

McGarry SD, Hurrell SL, Iczkowski KA, Hall W, Kaczmarowski AL, Banerjee A, Keuter T, Jacobsohn K, Bukowy JD, Nevalainen MT, Hohenwalter MD, See WA, LaViolette PS.

Int J Radiat Oncol Biol Phys. 2018 Aug 1;101(5):1179-1187. doi: 10.1016/j.ijrobp.2018.04.044. Epub 2018 Apr 24.

8.

Optimized b-value selection for the discrimination of prostate cancer grades, including the cribriform pattern, using diffusion weighted imaging.

Hurrell SL, McGarry SD, Kaczmarowski A, Iczkowski KA, Jacobsohn K, Hohenwalter MD, Hall WA, See WA, Banerjee A, Charles DK, Nevalainen MT, Mackinnon AC, LaViolette PS.

J Med Imaging (Bellingham). 2018 Jan;5(1):011004. doi: 10.1117/1.JMI.5.1.011004. Epub 2017 Oct 27.

9.

Ten-Year Review of Perioperative Complications After Transurethral Resection of Bladder Tumors: Analysis of Monopolar and Plasmakinetic Bipolar Cases.

Avallone MA, Sack BS, El-Arabi A, Charles DK, Herre WR, Radtke AC, Davis CM, See WA.

J Endourol. 2017 Aug;31(8):767-773. doi: 10.1089/end.2017.0056. Epub 2017 Jun 29.

10.

Toward Quantitative Whole Organ Thermoacoustics With a Clinical Array Plus One Very Low-Frequency Channel Applied to Prostate Cancer Imaging.

Patch SK, Hull D, See WA, Hanson GW.

IEEE Trans Ultrason Ferroelectr Freq Control. 2016 Feb;63(2):245-55. doi: 10.1109/TUFFC.2015.2513018. Epub 2015 Dec 29.

11.

The Dose-Response Relationship of bacillus Calmette-Guérin and Urothelial Carcinoma Cell Biology.

Shah G, Zhang G, Chen F, Cao Y, Kalyanaraman B, See WA.

J Urol. 2016 Jun;195(6):1903-10. doi: 10.1016/j.juro.2015.11.073. Epub 2015 Dec 13.

12.

Initial experience with ketamine-based analgesia in patients undergoing robotic radical cystectomy and diversion.

Jacobsohn K, Davis TD, El-Arabi AM, Tlachac J, Langenstroer P, O'Connor RC, Guralnick ML, See WA, Schlosser R.

Can Urol Assoc J. 2015 May-Jun;9(5-6):E367-71. doi: 10.5489/cuaj.2790.

13.

Thermoacoustic contrast of prostate cancer due to heating by very high frequency irradiation.

Patch SK, Hull D, Thomas M, Griep SK, Jacobsohn K, See WA.

Phys Med Biol. 2015 Jan 21;60(2):689-708. doi: 10.1088/0031-9155/60/2/689. Epub 2015 Jan 2.

18.

A comparison of case volumes among urologic surgeons identified on an industry-sponsored website to an all provider peer group.

See WA, Jacobson K, Derus S, Langenstroer P.

Urol Oncol. 2014 Nov;32(8):1095-100. doi: 10.1016/j.urolonc.2014.08.009. Epub 2014 Sep 30. Review.

PMID:
25260903
19.

Factors associated with adherence to an end-of-study biopsy: lessons from the prostate cancer prevention trial (SWOG-Coordinated Intergroup Study S9217).

Gritz ER, Arnold KB, Moinpour CM, Burton-Chase AM, Tangen CM, Probstfield JF, See WA, Lieber MM, Caggiano V, Moody-Thomas S, Szczepanek C, Ryan A, Carlin S, Hill S, Goodman PJ, Padberg RM, Minasian LM, Meyskens FL, Thompson IM Jr.

Cancer Epidemiol Biomarkers Prev. 2014 Aug;23(8):1638-48. doi: 10.1158/1055-9965.EPI-14-0202. Epub 2014 Jul 15.

20.

Senior medical student opinions regarding the ideal urology interview day.

Jacobs JC, Guralnick ML, Sandlow JI, Langenstroer P, Begun FP, See WA, O'Connor RC.

J Surg Educ. 2014 Nov-Dec;71(6):878-82. doi: 10.1016/j.jsurg.2014.05.009. Epub 2014 Jun 26.

PMID:
24981655
21.

Immediate total parenteral nutrition after radical cystectomy and urinary diversion.

Pham KN, Schwartz LW, Garg T, Langenstroer P, Guralnick ML, See WA, O'Connor RC.

WMJ. 2014 Feb;113(1):20-3.

22.

Re: use of advanced treatment technologies among men at low risk of dying from prostate cancer.

See WA.

Eur Urol. 2014 Jan;65(1):250. doi: 10.1016/j.eururo.2013.10.024. No abstract available.

PMID:
24289855
23.

V-Loc urethro-intestinal anastomosis during robotic cystectomy with orthotopic urinary diversion.

Pham KN, Sack BS, O'Connor RC, Guralnick ML, Langenstroer P, See WA, Jacobsohn K.

Can Urol Assoc J. 2013 Nov-Dec;7(11-12):E663-6. doi: 10.5489/cuaj.508.

24.

iNOS expression and NO production contribute to the direct effects of BCG on urothelial carcinoma cell biology.

Shah G, Zhang G, Chen F, Cao Y, Kalyanaraman B, See WA.

Urol Oncol. 2014 Jan;32(1):45.e1-9. doi: 10.1016/j.urolonc.2013.06.005. Epub 2013 Sep 17.

25.

A manpower calculus: the implications of SUO fellowship expansion on oncologic surgeon case volumes.

See WA.

Urol Oncol. 2014 Jan;32(1):42.e7-12. doi: 10.1016/j.urolonc.2013.05.003. Epub 2013 Aug 2.

PMID:
23911685
31.

Duloxetine for the treatment of post-prostatectomy stress urinary incontinence.

Neff D, Guise A, Guralnick ML, Langenstroer P, See WA, Jacobsohn KM, O'Connor RC.

Can Urol Assoc J. 2013 May-Jun;7(5-6):E260-2. doi: 10.5489/cuaj.318.

32.

Contributors to HMGB1 release by urothelial carcinoma cells in response to bacillus Calmette-Guérin.

Zhang G, Chen F, Cao Y, See WA.

J Urol. 2013 Oct;190(4):1398-403. doi: 10.1016/j.juro.2013.03.123. Epub 2013 Apr 11.

PMID:
23583857
33.

HMGB1 release by urothelial carcinoma cells in response to Bacillus Calmette-Guérin functions as a paracrine factor to potentiate the direct cellular effects of Bacillus Calmette-Guérin.

Zhang G, Chen F, Cao Y, Amos JV, Shah G, See WA.

J Urol. 2013 Sep;190(3):1076-82. doi: 10.1016/j.juro.2013.01.050. Epub 2013 Jan 23.

PMID:
23353043
34.

Pharmacokinetics of protocatechuic acid in mouse and its quantification in human plasma using LC-tandem mass spectrometry.

Chen W, Wang D, Wang LS, Bei D, Wang J, See WA, Mallery SR, Stoner GD, Liu Z.

J Chromatogr B Analyt Technol Biomed Life Sci. 2012 Nov 1;908:39-44. doi: 10.1016/j.jchromb.2012.09.032. Epub 2012 Sep 27.

35.

HMGB1 release by urothelial carcinoma cells is required for the in vivo antitumor response to Bacillus Calmette-Guérin.

Zhang G, Chen F, Cao Y, Johnson B, See WA.

J Urol. 2013 Apr;189(4):1541-6. doi: 10.1016/j.juro.2012.09.123. Epub 2012 Oct 2.

PMID:
23041342
36.

A synthetic polyvalent ligand for α5β1 integrin activates components of the urothelial carcinoma cell response to bacillus Calmette-Guérin.

Chen F, Zhang G, Cao Y, Wakim B, See WA.

J Urol. 2013 Mar;189(3):1104-9. doi: 10.1016/j.juro.2012.08.218. Epub 2012 Oct 8.

PMID:
22999999
37.
38.

Specific heat capacity of freshly excised prostate specimens.

Patch SK, Rao N, Kelly H, Jacobsohn K, See WA.

Physiol Meas. 2011 Nov;32(11):N55-64. doi: 10.1088/0967-3334/32/11/N02. Epub 2011 Oct 26.

PMID:
22027030
39.

The association of robotic surgical technology and hospital prostatectomy volumes: increasing market share through the adoption of technology.

Neuner JM, See WA, Pezzin LE, Tarima S, Nattinger AB.

Cancer. 2012 Jan 15;118(2):371-7. doi: 10.1002/cncr.26271. Epub 2011 Jun 29.

40.

Ex vivo thermoacoustic imaging over large fields of view with 108 MHz irradiation.

Eckhart AT, Balmer RT, See WA, Patch SK.

IEEE Trans Biomed Eng. 2011 Aug;58(8). doi: 10.1109/TBME.2011.2128319. Epub 2011 Mar 17.

PMID:
21421431
41.

Assessment and management of irritative voiding symptoms.

Guralnick ML, O'Connor RC, See WA.

Med Clin North Am. 2011 Jan;95(1):121-7. doi: 10.1016/j.mcna.2010.08.025. Review.

PMID:
21095416
43.

Candidate urinary biomarker discovery in ureteropelvic junction obstruction: a proteomic approach.

Mesrobian HG, Mitchell ME, See WA, Halligan BD, Carlson BE, Greene AS, Wakim BT.

J Urol. 2010 Aug;184(2):709-14. doi: 10.1016/j.juro.2010.03.061.

PMID:
20639044
44.

Antiandrogen monotherapy in patients with localized or locally advanced prostate cancer: final results from the bicalutamide Early Prostate Cancer programme at a median follow-up of 9.7 years.

Iversen P, McLeod DG, See WA, Morris T, Armstrong J, Wirth MP; Casodex Early Prostate Cancer Trialists' Group.

BJU Int. 2010 Apr;105(8):1074-81. doi: 10.1111/j.1464-410X.2010.09319.x.

45.

MB49 murine urothelial carcinoma: molecular and phenotypic comparison to human cell lines as a model of the direct tumor response to bacillus Calmette-Guerin.

Chen F, Zhang G, Cao Y, Hessner MJ, See WA.

J Urol. 2009 Dec;182(6):2932-7. doi: 10.1016/j.juro.2009.08.018. Epub 2009 Oct 23.

PMID:
19853870
46.

Laparoscopic mesh herniorrhaphy: impact on outcomes associated with radical retropubic prostatectomy.

Neff DA, See WA.

Urol Oncol. 2011 Jan-Feb;29(1):66-9. doi: 10.1016/j.urolonc.2009.06.006. Epub 2009 Oct 17.

PMID:
19837615
47.

Resonance metallic ureteral stents do not successfully treat ureteroenteric strictures.

Garg T, Guralnick ML, Langenstroer P, See WA, Hieb RA, Rilling WS, Sudakoff GS, O'Connor RC.

J Endourol. 2009 Jul;23(7):1199-201; discussion 1202. doi: 10.1089/end.2008.0454.

PMID:
19530950
48.

p21 Expression by human urothelial carcinoma cells modulates the phenotypic response to BCG.

See WA, Zhang G, Chen F, Cao Y.

Urol Oncol. 2010 Sep-Oct;28(5):526-33. doi: 10.1016/j.urolonc.2008.12.023. Epub 2009 May 17.

PMID:
19450997
49.
50.

Bacille-Calmette Guèrin induces caspase-independent cell death in urothelial carcinoma cells together with release of the necrosis-associated chemokine high molecular group box protein 1.

See WA, Zhang G, Chen F, Cao Y, Langenstroer P, Sandlow J.

BJU Int. 2009 Jun;103(12):1714-20. doi: 10.1111/j.1464-410X.2008.08274.x. Epub 2008 Dec 22.

Supplemental Content

Support Center